COVAX

Western Equatoria Ministry of Health and UNICEF are preparing for COVID-19 vaccination campaigns.

As participating countries look towards receiving their first batch of COVID-19 vaccines through the COVAX Facility, we examine how South Africa is ramping up its readiness.

From Liability Laws to Production Delays, the 2009 H1N1 Swine Flu Vaccine Rollout Offers a Cautionary Tale for Today.

In less than a year, the world has come together to develop effective COVID-19 vaccines and a multilateral platform for allocating them most efficiently around the world. But with the risk of vaccine nationalism still looming large, now is the time to finish the job.

For all of the good news about the arrival of safe and effective COVID-19 vaccines, the hard truth for the coming year is that global demand will outpace supply. Without a multilateral agreement to allocate doses globally, the road to recovery will be much longer than it otherwise could have been.

Answers to the most common questions about coronavirus vaccine development.

Reflections on 2020 from Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.

Before any COVID-19 vaccines can be delivered to the public, their use must be approved by national regulatory authorities. We look into the process before vaccines would be approved for distribution and use in Nigeria and South Africa.

The COVAX Facility plans to start rolling out the doses in early 2021 to high-risk groups in participating countries, with the aim of vaccinating up to 20% of populations of participating countries by the end of the year.

As we prepare for one of the world’s largest vaccination efforts, and on the occasion of International Migrants Day, we are coming to a critical reckoning: the need for inclusive approaches in our health-related thinking and practices has never been more urgent.